Stock Taper
SCREENER COMPARE ANY 2 STOCKS
EXCHANGE TRADED FUND

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF
$33.44 ▼ 1.93%
−$0.66 TODAY

FUND FACTS

Manager Roundhill Investments
Assets $64.61M
Expense ratio 0.59%
Inception May 21, 2024
Asset class Equity
Holdings 12
Volume 6K
Avg volume 22.02K

ABOUT THIS FUND

Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.

PRICE

$33.44 ▼ DOWN 1.93% (−$0.66)
$33.40$33.60$33.80$34.009:30 AM10:28 AM11:25 AM12:23 PM1:20 PM2:17 PM3:15 PM33.44

HOLDINGS

TOP 12 OF 12 · 57.70% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 LLY Eli Lilly and Company 12.01% 6.61K $7.76M
02 NVO Novo Nordisk A/S 11.93% 168.98K $7.71M
03 PFE Pfizer Inc. 7.17% 165.7K $4.63M
04 VKTX Viking Therapeutics, Inc. 4.67% 93.82K $3.02M
05 AMGN Amgen Inc. 4.44% 6.63K $2.87M
06 KLRA Kailera Therapeutics, Inc. 4.42% 176.24K $2.86M
07 AZN AstraZeneca PLC 3.18% 12.62K $2.05M
08 MBX MBX Biosciences, Inc. Common Stock 3.09% 31.68K $2M
09 GPCR Structure Therapeutics Inc. 2.61% 35.56K $1.68M
10 GILD Gilead Sciences, Inc. 1.93% 8.57K $1.25M
11 RYTM Rhythm Pharmaceuticals, Inc. 1.52% 9.19K $984.68K
12 WVE Wave Life Sciences Ltd. 0.73% 92.94K $468.41K

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 43.49% OF THE FUND
United States 43.49%
Denmark 18.35%
China 17.81%
Japan 5.31%
South Korea 5.08%
Switzerland 3.22%
United Kingdom 3.22%
Hong Kong 2.66%
— Other 0.86%